DOTmed December 11, 2024
HealthCare Business News

The U.S. proton therapy market, valued at $1.04 billion in 2024, is forecast to reach $2.67 billion by 2033, representing a compound annual growth rate (CAGR) of 10.97%.

Analysis from ResearchAndMarkets attributes the growth to increasing incidence of cancer, technological advancements in proton therapy, and broader insurance coverage.

Proton therapy offers precise targeting of cancer cells while sparing surrounding healthy tissue. This makes it particularly effective for tumors near critical organs, including the brain, heart, and spine. The treatment has gained traction for conditions such as pediatric cancers and head and neck cancers, and is also commonly used for prostate cancer.

Drivers of market growth

The rise in cancer diagnoses is a significant factor fueling demand for proton therapy. According...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Market Research, Medical Devices, Trends
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
How Trump’s second term will affect the medtech industry
Cala Health Snags $50M for At-Home Tremor Relief Therapy
A Lifetime Guarantee on a Shoulder Implant? This Device Maker Is Offering It Through Geisinger

Share This Article